Understanding the New EASL-EASD-EASO Guidelines on MASLD New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent...
Global Liver Institute Welcomes Larry R. Holden as CEO(Washington, D.C., September 3, 2024) – The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization,...
More Than a Cure, a Path to Improvement: Hepatitis C TreatmentHepatitis C infection, an infection of the liver by the hepatitis C virus, is a major global health concern, affecting millions....
Understanding the New EASL-EASD-EASO Guidelines on MASLDWho are EASL, EASD, EASO? EASL, EASD, and EASO are prominent European organizations in the field of health and medicine, each focusing...
GLI Celebrates FDA Approval of Livdelzi®, an Option in Personalizing PBC Treatment (Washington, D.C. August 14, 2024) – Global Liver Institute (GLI) celebrates the expansion of treatment options for...
Congress is entering the August recess period. Nevertheless, patients are increasingly signaling to policymakers their frustration related to coverage challenges and over-zealous utilization...
NASH Affects Millions, But the Future for Treatment Remains Brighter Than Ever Managing NASH/MASH is becoming more promising with new advancements. The recent FDA approval of resmetirom, which...
Thank you for reading Liver Cancer News! Liver cancer is associated with low five-year survival rates, often due to late-stage diagnosis of the disease. In many cases, symptoms are minimal or absent...
New App Helps Predict Pediatric Transplant Need Amplify your voice with the new Wilson’s disease advocacy toolkit Following the Policy brief on Wilson’s disease in 2023, the Health...
Global Fatty Liver Day 2024 was a huge success! Check out our "At a Glance" report for highlights. Stay tuned for the full Global Fatty Liver Day 2024 report. Endocrinologists and PCPs:...
Recent News
Congress reconvenes in September for its last push to legislate before the November elections Congress is entering a very busy work period in September, the last before the November elections. GLI is preparing for its Advanced Advocacy Academy (A3) and subsequent day...
Millennials and Generation X Face Higher Risk of Liver Cancer Than Previous Generations Thank you for being a part of Liver Cancer News! As we gear up for Liver Cancer Awareness Month next month, we are thrilled to announce the launch of a comprehensive patient...
Let’s Ensure Access to Treatment for PBC Patients - Pediatric & Rare Liver Diseases NewsAmplifying the rare liver disease voice for PBC patients during our monthly policy call Global Liver Institute’s August Pediatric and Rare Liver Diseases monthly...
Understanding the New EASL-EASD-EASO Guidelines on MASLD New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent advancements. They focus on early identification and intervention and the...
Global Liver Institute Welcomes Larry R. Holden as CEO(Washington, D.C., September 3, 2024) – The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed Larry R. Holden as the organization’s Chief Executive...
